86 related articles for article (PubMed ID: 34551070)
1. Diagnostic Strategies for Endemic Coronavirus Disease 2019 (COVID-19).
Kost GJ
Arch Pathol Lab Med; 2022 Jan; 146(1):16-25. PubMed ID: 34551070
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Increasing Disease Prevalence, False Omissions, and Diagnostic Uncertainty on Coronavirus Disease 2019 (COVID-19) Test Performance.
Kost GJ
Arch Pathol Lab Med; 2021 Jul; 145(7):797-813. PubMed ID: 33684204
[TBL] [Abstract][Full Text] [Related]
3. Designing and Interpreting Coronavirus Disease 2019 (COVID-19) Diagnostics: Mathematics, Visual Logistics, and Low Prevalence.
Kost GJ
Arch Pathol Lab Med; 2021 Mar; 145(3):291-307. PubMed ID: 32906146
[TBL] [Abstract][Full Text] [Related]
4. The Coronavirus Disease 2019 Spatial Care Path: Home, Community, and Emergency Diagnostic Portals.
Kost GJ
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626375
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Repeating COVID-19 Rapid Antigen Tests on Prevalence Boundary Performance and Missed Diagnoses.
Kost GJ
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892044
[TBL] [Abstract][Full Text] [Related]
6. Interpreting SARS-CoV-2 Diagnostic Tests: Common Questions and Answers.
Nettleton WD
Am Fam Physician; 2021 Apr; 103(8):465-472. PubMed ID: 33856162
[TBL] [Abstract][Full Text] [Related]
7. Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions?
Van Honacker E; Van Vaerenbergh K; Boel A; De Beenhouwer H; Leroux-Roels I; Cattoir L
J Hosp Infect; 2021 Aug; 114():144-152. PubMed ID: 33785377
[TBL] [Abstract][Full Text] [Related]
8. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
[TBL] [Abstract][Full Text] [Related]
9. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
[TBL] [Abstract][Full Text] [Related]
10. Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting.
Skittrall JP; Wilson M; Smielewska AA; Parmar S; Fortune MD; Sparkes D; Curran MD; Zhang H; Jalal H
Clin Microbiol Infect; 2021 Mar; 27(3):469.e9-469.e15. PubMed ID: 33068757
[TBL] [Abstract][Full Text] [Related]
11. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of a lateral flow assay for nasopharyngeal antigen detection for SARS-CoV-2 diagnosis.
Peña-Rodríguez M; Viera-Segura O; García-Chagollán M; Zepeda-Nuño JS; Muñoz-Valle JF; Mora-Mora J; Espinoza-De León G; Bustillo-Armendáriz G; García-Cedillo F; Vega-Magaña N
J Clin Lab Anal; 2021 May; 35(5):e23745. PubMed ID: 33675086
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
14. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic.
Pulia MS; O'Brien TP; Hou PC; Schuman A; Sambursky R
Ann Med; 2020 Aug; 52(5):207-214. PubMed ID: 32370561
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.
Prince-Guerra JL; Almendares O; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Shewmaker PL; Medrzycki M; Wong P; Jain S; Tejada-Strop A; Rogers S; Emery B; Wang H; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg NJ; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):100-105. PubMed ID: 33476316
[TBL] [Abstract][Full Text] [Related]
16. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
Gao J; Quan L
Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
[TBL] [Abstract][Full Text] [Related]
17. Geospatial Hotspots Need Point-of-Care Strategies to Stop Highly Infectious Outbreaks.
Kost GJ
Arch Pathol Lab Med; 2020 Oct; 144(10):1166-1190. PubMed ID: 32298139
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2.
Tollånes MC; Bakken Kran AM; Abildsnes E; Jenum PA; Breivik AC; Sandberg S
Clin Chem Lab Med; 2020 Aug; 58(9):1595-1600. PubMed ID: 32598303
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of antigen and molecular tests for the detection of Sars-CoV-2 and related variants: A study on 4266 samples.
Caputo V; Bax C; Colantoni L; Peconi C; Termine A; Fabrizio C; Calvino G; Luzzi L; Panunzi GG; Fusco C; Strafella C; Cascella R; Battistini L; Caltagirone C; Salvia A; Sancesario G; Giardina E
Int J Infect Dis; 2021 Jul; 108():187-189. PubMed ID: 33878460
[TBL] [Abstract][Full Text] [Related]
20. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
